Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a...
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada; hereinafter “Sumitomo Dainippon Pharma”) and Angelini S.p.A. announced...
Natural killer (NK) cells are lymphocytes of the innate immune system and are important in controlling tumors and infections without...
Swedish Orphan Biovitrum AB (Sobi) has announced that the first patient has been randomised in the phase 3 study anaSTILLs,...
ABIVAX announced the enrolment of the first patient in the ABX464-101 proof-of-concept study of its lead product candidate ABX464 in...
Apceth Biopharma GmbH announced today that it has been selected to present at the European Hematology Society (EHA)-SWG Scientific Meeting...
Novartis announced that the EC approved Tasigna® (nilotinib) for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic...
Wellthy Therapeutics a digital therapeutics company that uses artificial intelligence (AI) and patient centric design to improve patient outcomes is...
Eurofins Scientific, a global leader in bioanalytical testing, announces that it has acquired Spectro Analytical Labs Ltd. (“Spectro”), a leading...
Amgen announced that the ENBREL Mini with AutoTouch™ is now available in the United States (U.S.). Awarded the Arthritis Foundation...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
